EP1161255A4 - Verfahren und mittel zur behandlung erektiler dysfunktion - Google Patents
Verfahren und mittel zur behandlung erektiler dysfunktionInfo
- Publication number
- EP1161255A4 EP1161255A4 EP00916081A EP00916081A EP1161255A4 EP 1161255 A4 EP1161255 A4 EP 1161255A4 EP 00916081 A EP00916081 A EP 00916081A EP 00916081 A EP00916081 A EP 00916081A EP 1161255 A4 EP1161255 A4 EP 1161255A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- methods
- erectile dysfunction
- treating erectile
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12324499P | 1999-03-08 | 1999-03-08 | |
US123244P | 1999-03-08 | ||
PCT/US2000/005711 WO2000053148A2 (en) | 1999-03-08 | 2000-03-03 | Methods and compositions for treating erectile dysfunction |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1161255A2 EP1161255A2 (de) | 2001-12-12 |
EP1161255A4 true EP1161255A4 (de) | 2002-07-17 |
Family
ID=22407530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00916081A Withdrawn EP1161255A4 (de) | 1999-03-08 | 2000-03-03 | Verfahren und mittel zur behandlung erektiler dysfunktion |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1161255A4 (de) |
AU (1) | AU3724400A (de) |
CA (1) | CA2362918A1 (de) |
WO (1) | WO2000053148A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6548490B1 (en) * | 1997-10-28 | 2003-04-15 | Vivus, Inc. | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
US6403597B1 (en) | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
IL135817A0 (en) * | 1999-04-30 | 2001-05-20 | Lilly Icos Llc | Phosphodiesterase enzyme inhibitors and their use in pharmaceutical articles |
US6943166B1 (en) | 1999-04-30 | 2005-09-13 | Lilly Icos Llc. | Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction |
US7235625B2 (en) * | 1999-06-29 | 2007-06-26 | Palatin Technologies, Inc. | Multiple agent therapy for sexual dysfunction |
US7176279B2 (en) | 2000-06-28 | 2007-02-13 | Palatin Technologies, Inc. | Cyclic peptide compositions and methods for treatment of sexual dysfunction |
EP1200091B1 (de) | 1999-08-03 | 2008-07-02 | Lilly Icos LLC | Pharmazeutische zusammensetzung enthaltend tadalafil |
TWI265925B (en) | 1999-10-11 | 2006-11-11 | Pfizer | Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them |
AU2002238106A1 (en) | 2001-02-13 | 2002-08-28 | Palatin Technologies, Inc. | Melanocortin metallopeptides for treatment of sexual dysfunction |
DE60229393D1 (de) * | 2001-07-18 | 2008-11-27 | Merck & Co Inc | Überbrückte piperidinderivate als melanocortin-rezeptor-agonisten |
WO2004005324A2 (en) | 2002-07-09 | 2004-01-15 | Palatin Technologies, Inc. | Peptide composition for treatment of sexual dysfunction |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962528A (en) * | 1991-07-03 | 1999-10-05 | Scott; Nathan Earl | Prostaglandin E2 /F2α combination for treating impotence |
EP0611248B1 (de) * | 1993-02-10 | 2000-03-22 | B.M.R.A. Corporation B.V. | Zubereitungen zur Behandlung von Impotenz, die ein Alpha-1 inhibitor und ein Alpha-2 inhibitor enthalten |
JP3204510B2 (ja) * | 1993-04-05 | 2001-09-04 | コンペティティブ テクノロジーズ,インク. | 勃起不全の診断および治療 |
GB9301192D0 (en) * | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
GB9423911D0 (en) * | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
US5731339A (en) * | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
GB9514464D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
US5932538A (en) * | 1996-02-02 | 1999-08-03 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
US5994294A (en) * | 1996-02-02 | 1999-11-30 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
US6037346A (en) * | 1997-10-28 | 2000-03-14 | Vivus, Inc. | Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
TR200001733T2 (tr) * | 1997-12-16 | 2000-11-21 | Pfizer Products Inc | İktidarsızlığın tedavisi için etkili kombinasyon. |
AU1827299A (en) * | 1997-12-18 | 1999-07-05 | Nathan Earl Scott | Prostaglandin e2/f2alpha combination for treating impotence and enhancing sexual arousal |
GT199900061A (es) * | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
AU4068599A (en) * | 1998-05-20 | 1999-12-06 | Schering Corporation | Combination of phentolamine and cyclic gmp phosphodiesterase inhibitors for the treatment of sexual dysfunction |
US6124461A (en) * | 1998-05-26 | 2000-09-26 | Saint Louis University, Health Services Center, Research Administration | Compounds, compositions, and methods for treating erectile dysfunction |
US6200591B1 (en) * | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
US6007824A (en) * | 1998-07-09 | 1999-12-28 | Duckett; Melvin J. | Natural composition and method for the treatment of sexual dysfunction |
-
2000
- 2000-03-03 AU AU37244/00A patent/AU3724400A/en not_active Abandoned
- 2000-03-03 EP EP00916081A patent/EP1161255A4/de not_active Withdrawn
- 2000-03-03 CA CA002362918A patent/CA2362918A1/en not_active Abandoned
- 2000-03-03 WO PCT/US2000/005711 patent/WO2000053148A2/en active Search and Examination
Non-Patent Citations (3)
Title |
---|
HEDLUND-H ET AL.: "Pharmacotherapy in erectile dysfunction agents for self-injection programs and alternative application methods", SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, vol. 179, no. Suppl, 1996, pages 129 - 138, XP001064596 * |
HUNTER WESSELS ET AL.: "Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study", THE JOURNAL OF UROLOGY, vol. 160, 1998, pages 389 - 393, XP001064550 * |
See also references of WO0053148A3 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000053148A2 (en) | 2000-09-14 |
CA2362918A1 (en) | 2000-09-14 |
AU3724400A (en) | 2000-09-28 |
WO2000053148A3 (en) | 2000-12-14 |
EP1161255A2 (de) | 2001-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1005336A4 (de) | Verbesserte verfahren und zusammensetzungen zur behandlung männlicher erektionsstörungen | |
HUP0103346A3 (en) | Composition and method for treating penile erectile dysfunction | |
HUP0201436A3 (en) | Methods and compositions for treating solid tumors | |
EP1164848A4 (de) | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERMEIDUNG UND BEHANDLUNG SEXUELLER FUNKTIONSSTöRUNGEN | |
AP2006003708A0 (en) | Methods and compositions for treating flavivirusesand pestiviruses | |
EP1143987A4 (de) | Natürliche zusammensetzung und methode zur behandlung von sexuellen dysfunktionen | |
AU4768301A (en) | Synergistic methods and compositions for treating cancer | |
HK1049787B (zh) | 採用免疫共軛物和化療劑治療癌症的組合物以及方法 | |
GB9608408D0 (en) | Treatment of erectile dysfunction | |
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
HK1061669A1 (en) | Processes and compositions for water treatment | |
IL144517A0 (en) | Compositions and methods for treating cataracts | |
AU4314199A (en) | Compounds, compositions and methods for treating erectile dysfunction | |
AU2001250821A1 (en) | Methods and compositions for the treatment and prevention of erectile dysfunction | |
GB9920678D0 (en) | Sanitising compositions and methods | |
EP1161255A4 (de) | Verfahren und mittel zur behandlung erektiler dysfunktion | |
HU0001629D0 (en) | Method for treating plants and compositions for it | |
EP1677754A4 (de) | Verfahren und zusammensetzungen zur behandlung der erektilen dysfunktion | |
HUP0103206A3 (en) | A device and method for the treatment of erectile dysfunction and for its making | |
AU3048501A (en) | An improved pharmaceutical composition for treating male erectile dysfunction | |
EP1223957A4 (de) | Methode zur behandlung erektiler dysfunktion | |
IL149200A0 (en) | Peptides for treatment of erectile dysfunction | |
EP1261331A4 (de) | Methoden und zusammenstellungen zur behandlung von fibrotischen erkrankungen | |
EP1157694A4 (de) | Heilmittel der erektionsstörung | |
AU6733500A (en) | Agents for ameliorating erectile dysfunction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011008 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20011008;LT PAYMENT 20011008;LV PAYMENT 20011008;MK PAYMENT 20011008;RO PAYMENT 20011008;SI PAYMENT 20011008 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020531 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 38/08 A, 7A 61K 31/415 B, 7A 61K 31/505 B, 7A 61K 38/12 B, 7A 61P 15/10 B, 7A 61K 38/12 J, 7A 61K 31:00 J |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20020823 |